LGR6’s enrichment in advanced NSCLC and lung adenocarcinoma correlates with EMT and stem-like properties (60, 61), positioning it as a dual diagnostic/prognostic marker and druggable target. The gene discussed is LGR6; the disease is non-small cell lung carcinoma.